Does the media prefer AVR or WRBY?

In the previous week, Warby Parker had 8 more articles in the media than Anteris Technologies Global. MarketBeat recorded 13 mentions for Warby Parker and 5 mentions for Anteris Technologies Global. Warby Parker's average media sentiment score of 0.74 beat Anteris Technologies Global's score of 0.38 indicating that Warby Parker is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Anteris Technologies Global 1 Very Positive mention(s) 2 Positive mention(s) 1 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral Warby Parker 7 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media prefer AVR or ESTA?

In the previous week, Anteris Technologies Global had 3 more articles in the media than Establishment Labs. MarketBeat recorded 5 mentions for Anteris Technologies Global and 2 mentions for Establishment Labs. Establishment Labs' average media sentiment score of 1.81 beat Anteris Technologies Global's score of 0.38 indicating that Establishment Labs is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Anteris Technologies Global 1 Very Positive mention(s) 2 Positive mention(s) 1 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral Establishment Labs 2 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive

Does the media prefer AVR or AXGN?

In the previous week, Anteris Technologies Global had 1 more articles in the media than AxoGen. MarketBeat recorded 5 mentions for Anteris Technologies Global and 4 mentions for AxoGen. AxoGen's average media sentiment score of 1.30 beat Anteris Technologies Global's score of 0.38 indicating that AxoGen is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Anteris Technologies Global 1 Very Positive mention(s) 2 Positive mention(s) 1 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral AxoGen 3 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media refer more to AVR or TMDX?

In the previous week, TransMedics Group had 1 more articles in the media than Anteris Technologies Global. MarketBeat recorded 6 mentions for TransMedics Group and 5 mentions for Anteris Technologies Global. Anteris Technologies Global's average media sentiment score of 0.38 beat TransMedics Group's score of 0.17 indicating that Anteris Technologies Global is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Anteris Technologies Global 1 Very Positive mention(s) 2 Positive mention(s) 1 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral TransMedics Group 1 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Does the media refer more to AVR or BFLY?

In the previous week, Anteris Technologies Global had 1 more articles in the media than Butterfly Network. MarketBeat recorded 5 mentions for Anteris Technologies Global and 4 mentions for Butterfly Network. Anteris Technologies Global's average media sentiment score of 0.38 beat Butterfly Network's score of 0.33 indicating that Anteris Technologies Global is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Anteris Technologies Global 1 Very Positive mention(s) 2 Positive mention(s) 1 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral Butterfly Network 0 Very Positive mention(s) 1 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Anteris Technologies Global (AVR) Competitors

$10.24 0.00 (0.00%)

Closing price 07/2/2026 04:00 PM Eastern

Extended Trading

$10.24 -0.01 (-0.05%)

As of 07/2/2026 06:53 PM Eastern

Compare

AVR vs. WRBY, ESTA, AXGN, TMDX, and BFLY

Should you buy Anteris Technologies Global stock or one of its competitors? MarketBeat compares Anteris Technologies Global with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Anteris Technologies Global include Warby Parker (WRBY), Establishment Labs (ESTA), AxoGen (AXGN), TransMedics Group (TMDX), and Butterfly Network (BFLY). These companies are all part of the "medical equipment" industry.

How does Anteris Technologies Global compare to Warby Parker?

Anteris Technologies Global (NASDAQ:AVR) and Warby Parker (NYSE:WRBY) are both medical equipment companies, but which is the better business? We will contrast the two companies based on the strength of their institutional ownership, analyst recommendations, media sentiment, profitability, valuation, earnings, risk and dividends.

Anteris Technologies Global currently has a consensus price target of $16.00, suggesting a potential upside of 56.25%. Warby Parker has a consensus price target of $29.82, suggesting a potential upside of 2.20%. Given Anteris Technologies Global's higher possible upside, equities analysts clearly believe Anteris Technologies Global is more favorable than Warby Parker.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Anteris Technologies Global	1 Sell rating(s)	0 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.60
Warby Parker	0 Sell rating(s)	5 Hold rating(s)	10 Buy rating(s)	0 Strong Buy rating(s)	2.67

Warby Parker has higher revenue and earnings than Anteris Technologies Global. Anteris Technologies Global is trading at a lower price-to-earnings ratio than Warby Parker, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Anteris Technologies Global	$1.91M	521.86	-$94.14M	-$2.23	N/A
Warby Parker	$871.91M	3.58	$1.64M	$0.02	1,458.75

Warby Parker has a net margin of 0.15% compared to Anteris Technologies Global's net margin of -5,148.78%. Warby Parker's return on equity of 2.30% beat Anteris Technologies Global's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Anteris Technologies Global	-5,148.78%	-124.76%	-101.21%
Warby Parker	0.15%	2.30%	1.18%

Anteris Technologies Global has a beta of 1.65, meaning that its share price is 65% more volatile than the broader market. Comparatively, Warby Parker has a beta of 1.91, meaning that its share price is 91% more volatile than the broader market.

93.2% of Warby Parker shares are held by institutional investors. 4.5% of Anteris Technologies Global shares are held by insiders. Comparatively, 16.8% of Warby Parker shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

In the previous week, Warby Parker had 8 more articles in the media than Anteris Technologies Global. MarketBeat recorded 13 mentions for Warby Parker and 5 mentions for Anteris Technologies Global. Warby Parker's average media sentiment score of 0.74 beat Anteris Technologies Global's score of 0.38 indicating that Warby Parker is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Anteris Technologies Global	1 Very Positive mention(s)	2 Positive mention(s)	1 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral
Warby Parker	7 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

Warby Parker beats Anteris Technologies Global on 14 of the 16 factors compared between the two stocks.

How does Anteris Technologies Global compare to Establishment Labs?

Anteris Technologies Global (NASDAQ:AVR) and Establishment Labs (NASDAQ:ESTA) are both medical companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, analyst recommendations, profitability, risk, dividends, earnings, media sentiment and valuation.

Establishment Labs has a net margin of -19.05% compared to Anteris Technologies Global's net margin of -5,148.78%. Anteris Technologies Global's return on equity of -124.76% beat Establishment Labs' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Anteris Technologies Global	-5,148.78%	-124.76%	-101.21%
Establishment Labs	-19.05%	-218.77%	-12.31%

Anteris Technologies Global presently has a consensus target price of $16.00, suggesting a potential upside of 56.25%. Establishment Labs has a consensus target price of $87.14, suggesting a potential downside of 2.36%. Given Anteris Technologies Global's higher probable upside, equities research analysts plainly believe Anteris Technologies Global is more favorable than Establishment Labs.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Anteris Technologies Global	1 Sell rating(s)	0 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.60
Establishment Labs	1 Sell rating(s)	1 Hold rating(s)	7 Buy rating(s)	0 Strong Buy rating(s)	2.67

In the previous week, Anteris Technologies Global had 3 more articles in the media than Establishment Labs. MarketBeat recorded 5 mentions for Anteris Technologies Global and 2 mentions for Establishment Labs. Establishment Labs' average media sentiment score of 1.81 beat Anteris Technologies Global's score of 0.38 indicating that Establishment Labs is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Anteris Technologies Global	1 Very Positive mention(s)	2 Positive mention(s)	1 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral
Establishment Labs	2 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive

72.9% of Establishment Labs shares are held by institutional investors. 4.5% of Anteris Technologies Global shares are held by company insiders. Comparatively, 10.0% of Establishment Labs shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Anteris Technologies Global has a beta of 1.65, indicating that its share price is 65% more volatile than the broader market. Comparatively, Establishment Labs has a beta of 1.06, indicating that its share price is 6% more volatile than the broader market.

Establishment Labs has higher revenue and earnings than Anteris Technologies Global. Establishment Labs is trading at a lower price-to-earnings ratio than Anteris Technologies Global, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Anteris Technologies Global	$1.91M	521.86	-$94.14M	-$2.23	N/A
Establishment Labs	$211.08M	12.44	-$51.06M	-$1.49	N/A

Summary

Establishment Labs beats Anteris Technologies Global on 10 of the 16 factors compared between the two stocks.

How does Anteris Technologies Global compare to AxoGen?

Anteris Technologies Global (NASDAQ:AVR) and AxoGen (NASDAQ:AXGN) are both medical companies, but which is the better investment? We will compare the two businesses based on the strength of their dividends, media sentiment, risk, analyst recommendations, institutional ownership, profitability, valuation and earnings.

80.3% of AxoGen shares are held by institutional investors. 4.5% of Anteris Technologies Global shares are held by insiders. Comparatively, 2.4% of AxoGen shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

AxoGen has a net margin of -13.21% compared to Anteris Technologies Global's net margin of -5,148.78%. AxoGen's return on equity of -9.63% beat Anteris Technologies Global's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Anteris Technologies Global	-5,148.78%	-124.76%	-101.21%
AxoGen	-13.21%	-9.63%	-6.26%

AxoGen has higher revenue and earnings than Anteris Technologies Global. AxoGen is trading at a lower price-to-earnings ratio than Anteris Technologies Global, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Anteris Technologies Global	$1.91M	521.86	-$94.14M	-$2.23	N/A
AxoGen	$238.11M	10.25	-$15.70M	-$0.64	N/A

Anteris Technologies Global has a beta of 1.65, indicating that its share price is 65% more volatile than the broader market. Comparatively, AxoGen has a beta of 1.09, indicating that its share price is 9% more volatile than the broader market.

In the previous week, Anteris Technologies Global had 1 more articles in the media than AxoGen. MarketBeat recorded 5 mentions for Anteris Technologies Global and 4 mentions for AxoGen. AxoGen's average media sentiment score of 1.30 beat Anteris Technologies Global's score of 0.38 indicating that AxoGen is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Anteris Technologies Global	1 Very Positive mention(s)	2 Positive mention(s)	1 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral
AxoGen	3 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Anteris Technologies Global presently has a consensus price target of $16.00, indicating a potential upside of 56.25%. AxoGen has a consensus price target of $46.50, indicating a potential upside of 1.33%. Given Anteris Technologies Global's higher probable upside, research analysts plainly believe Anteris Technologies Global is more favorable than AxoGen.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Anteris Technologies Global	1 Sell rating(s)	0 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.60
AxoGen	1 Sell rating(s)	1 Hold rating(s)	9 Buy rating(s)	0 Strong Buy rating(s)	2.73

Summary

AxoGen beats Anteris Technologies Global on 10 of the 16 factors compared between the two stocks.

How does Anteris Technologies Global compare to TransMedics Group?

Anteris Technologies Global (NASDAQ:AVR) and TransMedics Group (NASDAQ:TMDX) are both medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their risk, institutional ownership, analyst recommendations, media sentiment, earnings, profitability, valuation and dividends.

TransMedics Group has a net margin of 27.04% compared to Anteris Technologies Global's net margin of -5,148.78%. TransMedics Group's return on equity of 22.38% beat Anteris Technologies Global's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Anteris Technologies Global	-5,148.78%	-124.76%	-101.21%
TransMedics Group	27.04%	22.38%	8.46%

99.7% of TransMedics Group shares are held by institutional investors. 4.5% of Anteris Technologies Global shares are held by company insiders. Comparatively, 6.9% of TransMedics Group shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Anteris Technologies Global has a beta of 1.65, suggesting that its stock price is 65% more volatile than the broader market. Comparatively, TransMedics Group has a beta of 1.89, suggesting that its stock price is 89% more volatile than the broader market.

In the previous week, TransMedics Group had 1 more articles in the media than Anteris Technologies Global. MarketBeat recorded 6 mentions for TransMedics Group and 5 mentions for Anteris Technologies Global. Anteris Technologies Global's average media sentiment score of 0.38 beat TransMedics Group's score of 0.17 indicating that Anteris Technologies Global is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Anteris Technologies Global	1 Very Positive mention(s)	2 Positive mention(s)	1 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral
TransMedics Group	1 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Anteris Technologies Global presently has a consensus target price of $16.00, suggesting a potential upside of 56.25%. TransMedics Group has a consensus target price of $134.50, suggesting a potential upside of 95.32%. Given TransMedics Group's higher probable upside, analysts clearly believe TransMedics Group is more favorable than Anteris Technologies Global.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Anteris Technologies Global	1 Sell rating(s)	0 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.60
TransMedics Group	0 Sell rating(s)	7 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.46

TransMedics Group has higher revenue and earnings than Anteris Technologies Global. Anteris Technologies Global is trading at a lower price-to-earnings ratio than TransMedics Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Anteris Technologies Global	$1.91M	521.86	-$94.14M	-$2.23	N/A
TransMedics Group	$605.49M	3.93	$190.29M	$4.40	15.65

Summary

TransMedics Group beats Anteris Technologies Global on 13 of the 16 factors compared between the two stocks.

How does Anteris Technologies Global compare to Butterfly Network?

Anteris Technologies Global (NASDAQ:AVR) and Butterfly Network (NYSE:BFLY) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their valuation, profitability, institutional ownership, media sentiment, earnings, risk, dividends and analyst recommendations.

In the previous week, Anteris Technologies Global had 1 more articles in the media than Butterfly Network. MarketBeat recorded 5 mentions for Anteris Technologies Global and 4 mentions for Butterfly Network. Anteris Technologies Global's average media sentiment score of 0.38 beat Butterfly Network's score of 0.33 indicating that Anteris Technologies Global is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Anteris Technologies Global	1 Very Positive mention(s)	2 Positive mention(s)	1 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral
Butterfly Network	0 Very Positive mention(s)	1 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Anteris Technologies Global has a beta of 1.65, indicating that its share price is 65% more volatile than the broader market. Comparatively, Butterfly Network has a beta of 2.05, indicating that its share price is 105% more volatile than the broader market.

Anteris Technologies Global currently has a consensus target price of $16.00, suggesting a potential upside of 56.25%. Butterfly Network has a consensus target price of $5.56, suggesting a potential downside of 27.66%. Given Anteris Technologies Global's stronger consensus rating and higher probable upside, equities analysts clearly believe Anteris Technologies Global is more favorable than Butterfly Network.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Anteris Technologies Global	1 Sell rating(s)	0 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.60
Butterfly Network	1 Sell rating(s)	2 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.33

Butterfly Network has higher revenue and earnings than Anteris Technologies Global. Butterfly Network is trading at a lower price-to-earnings ratio than Anteris Technologies Global, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Anteris Technologies Global	$1.91M	521.86	-$94.14M	-$2.23	N/A
Butterfly Network	$97.61M	20.06	-$77.06M	-$0.30	N/A

37.9% of Butterfly Network shares are held by institutional investors. 4.5% of Anteris Technologies Global shares are held by insiders. Comparatively, 22.0% of Butterfly Network shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Butterfly Network has a net margin of -73.63% compared to Anteris Technologies Global's net margin of -5,148.78%. Butterfly Network's return on equity of -34.41% beat Anteris Technologies Global's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Anteris Technologies Global	-5,148.78%	-124.76%	-101.21%
Butterfly Network	-73.63%	-34.41%	-23.91%

Summary

Butterfly Network beats Anteris Technologies Global on 9 of the 16 factors compared between the two stocks.

Get Anteris Technologies Global News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding AVR and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

AVR vs. The Competition

Export

Metric	Anteris Technologies Global	MED INSTRUMENTS Industry	Medical Sector	NASDAQ Exchange
Market Cap	$996.78M	$7.57B	$7.16B	$12.48B
Dividend Yield	N/A	1.32%	2.66%	6.52%
P/E Ratio	-4.59	52.12	28.02	24.70
Price / Sales	521.86	49.46	540.37	99.49
Price / Cash	N/A	26.72	49.26	57.09
Price / Book	-1,024.00	7.48	10.96	6.46
Net Income	-$94.14M	$159.19M	$3.57B	$337.01M
7 Day Performance	5.96%	-0.39%	2.12%	1.69%
1 Month Performance	6.22%	-0.43%	5.25%	3.81%
1 Year Performance	169.47%	3.14%	33.29%	23.90%

Anteris Technologies Global Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
AVR Anteris Technologies Global	3.1796 of 5 stars	$10.24 flat	$16.00 +56.3%	+169.5%	$996.78M	$1.91M	N/A	138	News Coverage
WRBY Warby Parker	2.7721 of 5 stars	$30.02 +2.7%	$29.82 -0.7%	+31.1%	$3.21B	$871.91M	1,501.80	4,036	News Coverage Insider Trade
ESTA Establishment Labs	1.5246 of 5 stars	$87.42 -1.1%	$87.14 -0.3%	+103.3%	$2.57B	$211.08M	N/A	1,004
AXGN AxoGen	2.0082 of 5 stars	$44.72 -0.5%	$46.50 +4.0%	+320.2%	$2.38B	$238.11M	N/A	450	News Coverage Positive News Analyst Upgrade
TMDX TransMedics Group	4.3196 of 5 stars	$67.29 -1.7%	$134.50 +99.9%	-46.5%	$2.33B	$605.49M	15.29	210	Analyst Forecast Gap Up

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:AVR) was last updated on 7/5/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Anteris Technologies Global (AVR) Competitors

AVR vs. WRBY, ESTA, AXGN, TMDX, and BFLY

How does Anteris Technologies Global compare to Warby Parker?

Summary

How does Anteris Technologies Global compare to Establishment Labs?

Summary

How does Anteris Technologies Global compare to AxoGen?

Summary

How does Anteris Technologies Global compare to TransMedics Group?

Summary

How does Anteris Technologies Global compare to Butterfly Network?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

AVR vs. The Competition

Anteris Technologies Global Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Anteris Technologies Global (AVR) Competitors

AVR vs. WRBY, ESTA, AXGN, TMDX, and BFLY

How does Anteris Technologies Global compare to Warby Parker?

Do analysts rate AVR or WRBY?

Which has preferable earnings & valuation, AVR or WRBY?

Is AVR or WRBY more profitable?

Which has more risk and volatility, AVR or WRBY?

Do insiders & institutionals hold more shares of AVR or WRBY?

Does the media prefer AVR or WRBY?

Summary

How does Anteris Technologies Global compare to Establishment Labs?

Is AVR or ESTA more profitable?

Do analysts rate AVR or ESTA?

Does the media prefer AVR or ESTA?

Do insiders and institutionals hold more shares of AVR or ESTA?

Which has more volatility and risk, AVR or ESTA?

Which has stronger valuation & earnings, AVR or ESTA?

Summary

How does Anteris Technologies Global compare to AxoGen?

Do institutionals and insiders have more ownership in AVR or AXGN?

Is AVR or AXGN more profitable?

Which has stronger earnings & valuation, AVR or AXGN?

Which has more volatility & risk, AVR or AXGN?

Does the media prefer AVR or AXGN?

Do analysts prefer AVR or AXGN?

Summary

How does Anteris Technologies Global compare to TransMedics Group?

Is AVR or TMDX more profitable?

Do institutionals & insiders believe in AVR or TMDX?

Which has more risk & volatility, AVR or TMDX?

Does the media refer more to AVR or TMDX?

Do analysts recommend AVR or TMDX?

Which has stronger valuation and earnings, AVR or TMDX?

Summary

How does Anteris Technologies Global compare to Butterfly Network?

Does the media refer more to AVR or BFLY?

Which has more risk and volatility, AVR or BFLY?

Do analysts prefer AVR or BFLY?

Which has higher valuation and earnings, AVR or BFLY?

Do insiders and institutionals hold more shares of AVR or BFLY?

Is AVR or BFLY more profitable?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

AVR vs. The Competition

Anteris Technologies Global Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools